A detailed history of James Investment Research Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, James Investment Research Inc holds 2,809 shares of UTHR stock, worth $1.09 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
2,809
Previous 2,804 0.18%
Holding current value
$1.09 Million
Previous $893,000 12.65%
% of portfolio
0.12%
Previous 0.11%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$311.04 - $363.55 $1,555 - $1,817
5 Added 0.18%
2,809 $1.01 Million
Q2 2024

Jul 30, 2024

SELL
$228.26 - $319.04 $4,336 - $6,061
-19 Reduced 0.67%
2,804 $893,000
Q1 2024

May 01, 2024

SELL
$210.76 - $249.51 $10,327 - $12,225
-49 Reduced 1.71%
2,823 $648,000
Q4 2023

Feb 06, 2024

SELL
$214.88 - $256.94 $2,363 - $2,826
-11 Reduced 0.38%
2,872 $631,000
Q3 2023

Oct 31, 2023

BUY
$211.82 - $248.24 $610,677 - $715,675
2,883 New
2,883 $651,000
Q1 2023

Apr 25, 2023

BUY
$212.99 - $276.17 $53,247 - $69,042
250 Added 114.68%
468 $105,000
Q4 2022

Jan 30, 2023

SELL
$205.95 - $280.43 $10,503 - $14,301
-51 Reduced 18.96%
218 $61,000
Q3 2022

Oct 31, 2022

BUY
$203.3 - $244.17 $36,594 - $43,950
180 Added 202.25%
269 $56,000
Q2 2022

Aug 01, 2022

BUY
$174.81 - $241.14 $15,558 - $21,461
89 New
89 $21,000
Q1 2022

Apr 22, 2022

SELL
$166.16 - $213.96 $31,238 - $40,224
-188 Closed
0 $0
Q4 2021

Jan 28, 2022

BUY
$184.32 - $216.08 $34,652 - $40,623
188 New
188 $41,000
Q2 2019

Jul 24, 2019

SELL
$76.06 - $120.81 $151,283 - $240,291
-1,989 Closed
0 $0
Q1 2019

Apr 26, 2019

SELL
$107.15 - $126.84 $3,214 - $3,805
-30 Reduced 1.49%
1,989 $233,000
Q4 2018

Jan 22, 2019

SELL
$101.4 - $128.73 $1.68 Million - $2.14 Million
-16,611 Reduced 89.16%
2,019 $220,000
Q3 2018

Oct 26, 2018

SELL
$113.81 - $129.46 $318,326 - $362,099
-2,797 Reduced 13.05%
18,630 $2.38 Million
Q2 2018

Jul 19, 2018

BUY
$101.14 - $118.31 $2.17 Million - $2.54 Million
21,427 New
21,427 $2.43 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.